The Effect of Resistance Exercise on Inflammation in Young and Older Adults

January 12, 2023 updated by: National Taiwan Normal University

The Acute Effect of High-load Resistance Exercise on Inflammation in Young and Older Adults

Healthy young and older adults will complete two trials in a randomized crossover counter-balanced order, including resistance exercise and sedentary control. During each trial, blood samples will be collected.

The investigators hypothesized that an acute bout of resistance exercise exert different inflammation responses in young and older adults.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 162
        • National Taiwan Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Age: 20-80
  • Healthy male
  • Without experience of resistance training

Exclusion Criteria:

  • No acute or chronic musculoskeletal symptoms
  • Smoking
  • Alcohol or drug abuse
  • Fail to conduct resistance exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Sedentary control
Subjects in control trial stayed sedentary during the period.
Experimental: High-load resistance exercise
Subjects in high-load trial performed 3 sets per exercise, 8 repetitions with load of 70%-1RM with 90 sec of rest between sets, followed by a fourth set to voluntary failure.
4 total resistance exercises that target all major muscle groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in biomarkers of inflammation
Time Frame: 24-hour during each study intervention
Biomarkers of inflammation will be measured such as IL-10 in pg/mL, IL-6 in pg/mL, TNF-α in pg/mL.
24-hour during each study intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Borgs Ratings of Perceived Exertion (RPE)
Time Frame: 1-hour during each exercise intervention
Borgs RPE is a method of estimating exertion rating, based on a 6 to 20 rating scale (6 being the no exertion at all, 20 being maximal exertion).
1-hour during each exercise intervention
Changes in glucose
Time Frame: 24-hour during each study intervention
glucose in mg/dL
24-hour during each study intervention
Changes in metabolic parameters
Time Frame: 24-hour during each study intervention
Metabolic parameters will be measured such as TC in mg/dL, TG in mg/dL, and HDL in mg/dL.
24-hour during each study intervention
Changes in biomarkers of muscle damage
Time Frame: 24-hour during each study intervention
Biomarkers of muscle damage will be measured such as CK in U/L and LDH in U/L.
24-hour during each study intervention
Changes in molecular markers in peripheral blood mononuclear cells (PBMC)
Time Frame: 24-hour during each study intervention
Molecular markers in PBMC will be measured such as STAT3 in arbitrary units, IKK in arbitrary units, IkB in arbitrary units, p65 in arbitrary units, SOCS3 in arbitrary units, AMPK in arbitrary units, and SIRT1 in arbitrary units.
24-hour during each study intervention
Changes in complete blood count (CBC)
Time Frame: 24-hour during each study intervention
The white blood cell count and the count of each white blood cell type will be measured.
24-hour during each study intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hung-wen Liu, Ph.D., National Taiwan Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

September 2, 2021

First Submitted That Met QC Criteria

September 10, 2021

First Posted (Actual)

September 13, 2021

Study Record Updates

Last Update Posted (Estimate)

January 13, 2023

Last Update Submitted That Met QC Criteria

January 12, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202012HM020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Response

Clinical Trials on Resistance exercise

Subscribe